Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants – Effect on Respiratory Morbidity

Related Clinical Trial
Phase 1 Trial of Inhaled Tobramycin in BPD The Budesonide in Babies (BiB) Trial Follow-up Results of Newborns With Tracheostomy Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia Prolonged Outcomes After Nitric Oxide (PrONOx) A Study of Tobacco Smoke and Children With Respiratory Illnesses Delivery Room CPAP in Extremely Low Birth Weight Infants Dexamethasone Therapy in VLBW Infants at Risk of CLD Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children Estimating Length of Endotracheal Tube Insertion Using Gestational Age or Nasal-Tragus Length in Newborn Infants MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children Seattle-PAP Bubble Nasal CPAP and Work of Breathing High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC High Frequency Ventilation in Premature Infants (HIFI) Early Caffeine in Preterm Neonates High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance. Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants Non-invasive Respiratory Support in Preterm Infants Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants. The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS Work of Breathing During Non-invasive Ventilation in Premature Neonates Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants Intratracheal Budesonide/Surfactant Prevents BPD Bronchopulmonary Disease (BPD) Patient Registry Premature Birth and Its Sequelae in Women Inhaled NO in Prevention of Chronic Lung Disease The Effects of Position on the Oxygenation Instability of Premature Infants as Documented by SpO2 Histograms Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants – Effect on Respiratory Morbidity Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room Growth of Airways and Lung Tissues in Premature and Healthy Infants Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants Assessment of Lung Structure and Function of Infants Born Prematurely Post-hospitalization Nursing Effectiveness (PHONE) Study Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS) Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes Inhaled Beclomethasone to Prevent Chronic Lung Disease Work of Breathing in Premature Infants at Discharge Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome Hydrocortisone for BPD Clinic Features and Outcome of BPD (SGBPD) Neolifes Heart – Pulmonary Hypertension in Preterm Children Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia Management of Hyponatremia in Preterm Infants on Diuretics Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial Respiratory Outcome at Adolescence of Very Low Birthweight Infants Surfactant Administration During Spontaneous Breathing Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease Developmental Sequelae of Severe Chronic Lung Disorders Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator Improving Prematurity-Related Respiratory Outcomes at Vanderbilt Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease – The AD-ON Study Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns Azithromycin in the Prevention of Lung Injury in Premature Newborn Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation MRI in BPD Subjects A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease Early Versus Late Caffeine for ELBW Newborns Assessment of Lung Aeration at Birth MRI of Lung Structure and Function in Preterm Children BPD Saturation TARgeting Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD Antecedents of Bronchopulmonary Dysplasia Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood Aerosolized Albuterol Use in Severe BPD Late Sequelae of Bronchopulmonary Dysplasia Montelukast in Very Low Birthweight Infants Preterm Infant Inhaled Albuterol Dosing 129Xe MRI in Pediatric Population With BPD Investigation of Polymorphisms in Bronchopulmonary Dysplasia In Turkish Population Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes Comparison of Classification Standards of BPD in Premature Infants Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia Safety of Sildenafil in Premature Infants Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia Trial II of Lung Protection With Azithromycin in the Preterm Infant Forced Oscillometry in Infants With Bronchopulmonary Dysplasia The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia Fluid Filled Lung Oxygenation Assistance Trial Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project) Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants. Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia Physiologic Definition of Bronchopulmonary Dysplasia Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) – a US Study Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD) Mesenchymal Stem Cells for The Treatment of Bronchopulmonary Dysplasia in Infants p16Ink4a in Bronchopulmonary Dysplasia in Children Transpyloric Feeding in Severe Bronchopulmonary Dysplasia Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates Stem Cells for Bronchopulmonary Dysplasia Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD) Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia. Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia

Brief Title

Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants - Effect on Respiratory Morbidity

Official Title

Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants - Effects on Respiratory Morbidity: A Multicentre Randomised Controlled Clinical Trial

Brief Summary

      Chronic Lung Disease (CLD) of Prematurity is a common yet challenging co-morbidity affecting
      extremely premature newborns. Multifactorial influences leading to this co-morbidity is known
      and targeted in various research studies. Gastroesophageal reflux (GER) is common among the
      same cohort of patients. The investigators hypothesize that recurrent milk reflux into the
      airways of the premature babies worsen the inflammation of premature lungs and is a major
      contributor of CLD.

      The investigators hypothesize that Continuous feeding (CF) minimises GER and
      micro-aspiration, thereby reducing the incidence and severity of CLD in high-risk infants.

      Our aim is to compare the effect of intermittent bolus versus continuous intra-gastric
      feeding on the incidence and severity of CLD in very low birth weight infants ≤ 1250 grams.
    

Detailed Description

      The pathogenesis of bronchopulmonary dysplasia (BPD) is complex and multifactorial. As a
      result of premature birth, developmental arrest during a critical period of fetal lung
      development compounded by mechanical, oxidative and other injuries sustained during neonatal
      respiratory care forms the basis of pathogenesis. BPD affects up to 50% of infants with birth
      weight less than 1000 g. Between 2000 and 2009, despite advancement of neonatal care, annual
      BPD rates reported by Vermont Oxford Network among very low birth weight infants varied from
      26.2% to 30.4% without any decline. Severely affected infants often require prolonged
      ventilation, high oxygen use, alternative airway and several potent medications over the
      first few months to years of their lives. High mortality rates, neurodevelopmental delay,
      respiratory morbidity and growth failure are associated with BPD.

      Treatment of severe BPD with or without pulmonary hypertension is challenging. Prolonging the
      pregnancy in the face of premature labour, treating perinatal infections, augmenting
      pulmonary maturity with corticosteroids, judicious oxygen use, lung protective ventilation
      and optimizing nutrition to promote growth are important and well established measures to
      prevent or modify the progress of the chronic lung disease.

      It is common to find infants with BPD also having significant symptoms of reflux.
      Gastroesophageal reflux (GER) is a well-known co-morbidity among preterms and ex-preterms on
      chronic ventilation, many of whom go on to require surgical fundoplication to stop the reflux
      thus preventing further lung damage. Some have reported dramatic respiratory improvement
      after resolution of GER. In the early days of a preterm baby with respiratory distress, GER
      is common and silent. Among infants, diagnosis of pathologic GER from a benign one is
      difficult. Many neonatal intensive care units (NICUs) would investigate for GER only when
      faced with moderate to severe BPD to achieve better respiratory symptom control. However GER
      has not been studied well as a factor precipitating the development of BPD among VLBW
      neonates. This is the focus of the study.

      Aspiration of gastric contents into the lung is a widespread phenomenon in mechanically
      ventilated preterm infants. In animal models of gastric aspiration, gastric particulates
      altered the pulmonary mechanics, increased pulmonary inflammatory cells, released
      pro-inflammatory mediators, and inactivated surfactant. Development of bacterial pneumonia is
      a well-recognized complication following aspiration of gastric contents. The investigators
      hypothesize that repeated aspirations would aggravate and accelerate an inflammatory response
      in the lung finally leading on to BPD. In addition oxygen mediated damage and mechanical
      ventilation potentiate lung injury due to aspiration. Logically, if GER and aspiration could
      be minimized, it could decrease the incidence and severity of BPD.

      Certain positioning of the baby, small volume of feed increment, keeping a close watch on
      feed tolerance are practical ways of improving feeding tolerance and reducing GER. The
      intermittent bolus intra-gastric feeding method is commonly used to feed premature babies.
      Other alternatives are continuous intra-gastric (feed volume is slowly infused in the stomach
      over couple of hours through the nasogastric tube) and continuous transpyloric feeding
      (feeding tube passes beyond the stomach to the duodenum and feed volume is slowly infused
      over hours). Transpyloric continuous feeding as compared to intermittent gastric bolus
      feeding, has been found to significantly reduce ventilatory support requirements in extremely
      low birth weight (ELBW) infants, possibly via its effect of minimising GER. In this study,
      none of the babies who received transpyloric feeding developed significant BPD and in
      addition babies with significant BPD improved after switching to transpyloric method.
      Transpyloric feeding tubes however are challenging to insert, and intestinal perforation is
      an uncommon but significant adverse effect. This feeding method is also not physiological as
      it bypasses the stomach. It remains to be seen if continuous gastric feeds, which is easily
      administered and safer, would yield some of the advantages of continuous transpyloric feeds
      over intermittent gastric feeding.

      A Cochrane review in 2011 of continuous intra-gastric versus intermittent bolus intra-gastric
      feeding for premature infants found conflicting results, and was unable to make
      recommendations regarding the benefits and risks of these feeding methods. Clinical outcomes
      of interest from these trials were related to growth, feeding tolerance and gastrointestinal
      complications. The Cochrane review importantly found no significant difference in somatic
      growth and incidence of necrotising enterocolitis (NEC) between either feeding methods.
      Another Cochrane review in 2014 did not identify any randomised trial that evaluated the
      effects of continuous versus intermittent bolus intragastric tube feeding on
      gastro-oesophageal reflux disease in preterm and low birth weight infants and opined that
      well-designed and adequately powered trials are needed in this field. There were no studies
      comparing the effect of the above feeding methods on respiratory outcomes either.

      Trial objectives

      Aim: To compare the effect of intermittent bolus versus continuous intra-gastric feeding on
      the incidence and severity of BPD in very low birth weight infants (≤ 1250 grams).

      Hypothesis: Continuous feeding (CF) minimises silent GER and micro-aspiration, thereby
      reducing the incidence and severity of bronchopulmonary dysplasia (BPD) in high-risk infants
      when compared to intermittent bolus feeding (BF).

      Statistical considerations

      Sample size calculation: based on 2015 data from the Singapore National Very-Low-Birth-Weight
      (VLBW) Infant Network for infants ≤ 1250 grams, mortality rate was 12.9% and BPD rate
      (defined as any oxygen supplementation or any respiratory support at 36 weeks
      post-conceptional age) was 29.4%. Thus the composite primary outcome rate was 42.3%. For a
      primary outcome rate reduction from 45% to 22.5%, with a type 1 error rate of 5% and a power
      of 80%, a sample size of 68 infants in each arm is required, giving a total sample size of
      136 infants.
    


Study Type

Interventional


Primary Outcome

Incidence of BPD

Secondary Outcome

 Invasive Ventilatory requirements

Condition

Chronic Lung Disease of Prematurity

Intervention

Method of feeding; continuous feeding OR bolus feeding

Study Arms / Comparison Groups

 Continuous feeding (CF)
Description:  Infants fed through a naso or orogastric tube in a continuous fashion using syringe pump. Each feed cycle is of 4 hours (3 hrs continuous feeding and 1 hour rest). 6 feed cycles in a day.
Feed volume increment per day is as per departmental protocol and same as comparator arm.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Other

Estimated Enrollment

150

Start Date

December 3, 2019

Completion Date

December 2022

Primary Completion Date

June 2022

Eligibility Criteria

        Inclusion Criteria:

          -  Infants with a birth weight <1250g and a gestational age of between 24+0 - 33+6 weeks

        Exclusion Criteria:

          1. Major congenital malformation

          2. Chromosomal abnormality

          3. 10-minute Apgar score of =3

          4. Not expected to survive beyond 72 hours of age

          5. Bilateral grade 4 intraventricular haemorrhage (IVH)

          6. Did not consent / Consent not available
      

Gender

All

Ages

N/A - 3 Days

Accepts Healthy Volunteers

No

Contacts

Agnihotri Biswas, MRCPCH, +65 67725075, [email protected]

Location Countries

Malaysia

Location Countries

Malaysia

Administrative Informations


NCT ID

NCT03961139

Organization ID

2018/00773


Responsible Party

Sponsor

Study Sponsor

National University Hospital, Singapore


Study Sponsor

Agnihotri Biswas, MRCPCH, Principal Investigator, Senior Consultant Neonatologist, NUH Singapore


Verification Date

May 2019